CAS 1192171-69-9

Fórmula: C19H15Cl3N2O5S

InChI: InChI=1S/C19H15Cl3N2O5S/c20-12-2-1-3-13(21)18(12)30(27,28)24-8-6-23(7-9-24)14-4-5-15-11(17(14)22)10-16(29-15)19(25)26/h1-5,10H,6-9H2,(H,25,26)

Clave InChI: XLGQSYUNOIJBNR-UHFFFAOYSA-N

SMILES: C1CN(CCN1C2=C(C3=C(C=C2)OC(=C3)C(=O)O)Cl)S(=O)(=O)C4=C(C=CC=C4Cl)Cl

4-Chloro-5-(4-((2,6-Dichlorophenyl)Sulfonyl)Piperazin-1-Yl)Benzofuran-2-Carboxylic Acid

CAS: 1192171-69-9

4-Chloro-5-(4-((2,6-Dichlorophenyl)Sulfonyl)Piperazin-1-Yl)Benzofuran-2-Carboxylic Acid

Fórmula: C₁₉H₁₅Cl₃N₂O₅S

Pureza: 98%

Peso molecular: 489.76

Ref: 54-OR1023053

Vonafexor

CAS: 1192171-69-9

Vonafexor

Fórmula: C₁₉H₁₅Cl₃N₂O₅S

Pureza: 98.5%

Peso molecular: 489.76

Ref: 54-BUP06737

4-Chloro-5-(4-((2,6-dichlorophenyl)sulfonyl)piperazin-1-yl)benzofuran-2-carboxylic acid

CAS: 1192171-69-9

Fórmula: C₁₉H₁₅Cl₃N₂O₅S

Pureza: 98%

Forma y color: Solid

Peso molecular: 489.7568

Ref: IN-DA01V2UY

Vonafexor

CAS: 1192171-69-9

Vonafexor (EYP001) is a farnesoid X receptor (FXR, NR1H4) agonist, with anti-HBV effects

Fórmula: C₁₉H₁₅Cl₃N₂O₅S

Pureza: 98.74%

Forma y color: White Solid

Peso molecular: 489.757

Ref: TM-T8471

Vonafexor

CAS: 1192171-69-9

4-Chloro-5-(4-((2,6-dichlorophenyl)sulfonyl)piperazin-1-yl)benzofuran-2-carboxylic acid

Fórmula: C₁₉H₁₅Cl₃N₂O₅S

Pureza: 98%

Peso molecular: 489.76

Ref: IN-DG01218047

Vonafexor

CAS: 1192171-69-9

Vonafexor is an inhibitor that is used in combination with other drugs for the treatment of non-alcoholic steatohepatitis. Vonafexor is a potent inhibitor of fatty acid synthase, which may be responsible for the reduction of liver fat and inflammation in patients with non-alcoholic steatohepatitis. It has also been shown to inhibit lipoprotein lipase and block sterol uptake, leading to decreased cholesterol synthesis. Vonafexor has not been associated with any adverse events and has no known drug interactions.

Fórmula: C₁₉H₁₅Cl₃N₂O₅S

Pureza: Min. 95%

Peso molecular: 489.8 g/mol

Ref: 3D-SXB17169